With the MHRA approval and UK availability of the daily Wegovy® (semaglutide) tablet, adults seeking effective weight management now have more options than ever. Alongside weekly self-injections like Mounjaro® (tirzepatide) and the Wegovy® prefilled pen, UK patients can choose between daily oral tablets and weekly injections.
To compare treatment options, review prescribed dosage guidelines, or complete a medical consultation, visit the WellAssist Weight Management Hub. You can also explore our core primary care services, including Situational Anxiety Treatments and Propranolol Services.The Science in 60 Seconds
Direct Answer: Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that yields the highest average weight loss in clinical trials (up to 22.5% body weight reduction). The Wegovy Injection (semaglutide) is a single GLP-1 receptor agonist offering up to 21% weight loss at its maximum 7.2mg dose, alongside proven cardiovascular protection. The Wegovy Pill (oral semaglutide) provides up to 17% weight loss in daily tablet form, eliminating needle anxiety while utilizing the same active molecule as the injection.
Head-to-Head Comparison: UK Weight Loss Interventions
| Feature | Wegovy® Oral Pill | Wegovy® Weekly Pen | Mounjaro® Weekly Pen | Top Page Link |
| Active Ingredient | Semaglutide | Semaglutide | Tirzepatide | Weight Management |
| Mechanism of Action | Single GLP-1 Receptor Agonist | Single GLP-1 Receptor Agonist | Dual GIP & GLP-1 Receptor Agonist | WellAssist Pharmacy Hub |
| Average Weight Loss | Up to 17% | Up to 21% (7.2mg) | Up to 22.5% (15mg) | Weight Management |
| Administration | Daily tablet (on empty stomach) | Once-weekly subcutaneous injection | Once-weekly subcutaneous injection | Weight Management |
| Dose Titration Schedule | 1.5mg, 4mg, 9mg, 25mg | 0.25mg up to 2.4mg / 7.2mg | 2.5mg up to 15mg | Weight Management |
| Injection Site Reactions | None | Possible mild localized redness | Possible mild localized redness | WellAssist Hub |
Key Distinctions Between Treatments
1. Single vs. Dual Hormone Action
- Semaglutide (Wegovy): Mimics the natural GLP-1 hormone, slowing gastric emptying and binding to satiety centers in the hypothalamus to reduce appetite and curb food noise.
- Tirzepatide (Mounjaro): Mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) hormones. GIP enhances how the body breaks down fat and processes sugar, resulting in slightly higher overall weight loss in clinical head-to-head trials.
2. Daily Oral vs. Weekly Injection
- The Wegovy Pill: Requires strict morning adherence. It must be swallowed with a small sip of water (no more than 120ml) on an empty stomach at least 30 minutes before consuming any food, drink, or other oral medications.
- Injectable Pens: Administered once a week under the skin (abdomen, thigh, or upper arm) on the same day each week, regardless of meals.
Clinical Guidelines & Best Practices
Switch Under Medical Supervision: Patients looking to switch from an injection to the oral tablet (or vice versa) must consult their prescriber to ensure safe dose alignment.
Follow the Titration Schedule: All three options require starting at a low introductory dose and gradually increasing every 4 weeks. This step-up process allows the gastrointestinal tract to adjust, reducing common side effects like mild nausea or bloating.
Prioritize Lean Protein & Hydration: Adequate fluid intake and high protein intake (1.2g–1.5g per kg target weight) help preserve lean muscle mass during weight reduction.
In clinical trials, the daily Wegovy pill achieved an average body weight loss of up to 17%, compared to up to 21% for the highest-dose weekly injection (7.2mg). While injections yield slightly higher weight reduction, the pill provides an effective, needle-free alternative for daily management.
Yes, but access remains restricted. NHS prescribing typically requires a referral to tier-3 specialist weight management services, alongside specific BMI thresholds and obesity-related health complications (such as hypertension or type 2 diabetes). Private consultations are available through regulated platforms like WellAssist Weight Management.
